Cubist Systematic Strategies, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,793,617
+46.4%
219,624
+77.9%
0.02%
+75.0%
Q1 2023$1,907,861
-13.9%
123,486
-8.6%
0.01%
-7.7%
Q4 2022$2,215,305
-62.2%
135,162
-57.3%
0.01%
-60.6%
Q3 2022$5,859,000
+147.3%
316,713
+75.8%
0.03%
+135.7%
Q2 2022$2,369,000
+90.4%
180,143
+34.2%
0.01%
+40.0%
Q1 2022$1,244,000
-16.2%
134,239
-11.7%
0.01%
-28.6%
Q4 2021$1,485,000
+75.7%
152,031
+511.7%
0.01%
+27.3%
Q3 2021$845,000
+16800.0%
24,855
+17910.9%
0.01%
Q2 2021$5,000
-98.5%
138
-98.1%
0.00%
-100.0%
Q1 2021$329,000
-73.4%
7,335
-66.2%
0.00%
-76.5%
Q4 2020$1,239,000
+74.3%
21,704
+56.7%
0.02%
+54.5%
Q3 2020$711,000
+213.2%
13,852
+264.5%
0.01%
+175.0%
Q2 2020$227,000
-69.8%
3,800
-79.2%
0.00%
-80.0%
Q1 2020$751,000
-85.1%
18,246
-77.5%
0.02%
-78.3%
Q4 2019$5,038,000
+12187.8%
80,951
+6645.9%
0.09%
+9100.0%
Q3 2019$41,000
-86.6%
1,200
-91.2%
0.00%
-83.3%
Q2 2019$306,000
+51.5%
13,563
+55.7%
0.01%
-14.3%
Q1 2019$202,000
-54.3%
8,709
-58.7%
0.01%
-66.7%
Q4 2018$442,00021,0730.02%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$72,236,00020.73%
SV Health Investors, LLC 449,951$26,871,00018.64%
Redmile Group, LLC 4,978,941$297,342,0005.49%
Sunesis Advisors, LLC 96,299$5,751,0005.29%
Eversept Partners, LP 418,652$25,001,8973.43%
Opaleye Management Inc. 222,000$13,081,0002.64%
Avoro Capital Advisors LLC 1,860,000$111,079,0002.20%
SPHERA FUNDS MANAGEMENT LTD. 282,965$16,899,0001.59%
SECTORAL ASSET MANAGEMENT INC 224,359$13,399,0001.23%
Artal Group S.A. 650,000$38,818,0001.09%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders